arrow
G

Gini F. Fleming

university of chicago
H指数:80
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer

SOFT和TEXT III期试验在绝经前激素受体阳性早期乳腺癌中的最终结果

2026-06-010
PRE
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT

TEXT和SOFT研究中激素受体阳性早期乳腺癌女性患者报告抑郁的预后价值

Cancer
IF5.1
2025-09-230
PRE
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer

卡铂、吉西他滨和米非司酮用于晚期乳腺癌和复发性/持续性上皮性卵巢癌

2025-08-080
OA
Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results

Veliparib联合一线化疗及作为卵巢癌的维持治疗:最终总生存期及疾病相关症状结果

2025-06-170
PRE
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

nab-紫杉醇联合或不联合米非司酮治疗晚期三阴性乳腺癌的随机II期试验

2025-02-100
OAAI
Lasofoxifene versus fulvestrant for ERD/HER2L metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial

Lasofoxifene与fulvestrant治疗ESR1突变的ERD/HER2L转移性乳腺癌: 来自随机,II期ELAINE 1试验的结果

2023-12-0112
OA